Skip to main content
OpenTrials

Clinical trial condition

Embolism and Thrombosis

Explore clinical trials studying Embolism and Thrombosis. Study availability and eligibility vary by location and protocol.

2,298 public trials 309 recruiting studies
Refine in advanced search Browse all conditions

Embolism and Thrombosis trial results

Completed

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

NCT01166685

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +8 more
Locations
  • Universitätsklinikum Innsbruck, Austria
  • Gentofte Hospital Hellerup, Denmark
  • Elisabethen Krankenhaus Essen, North Rhine-Westphalia, Germany
  • Kantonsspital Aarau, Canton of Aargau, Switzerland
View Trial Details
Completed

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

NCT01272453

Conditions
Aneurysm, Aortic Aneurysm, Aortic Diseases, +18 more
Locations
  • Naval Medical Center San Diego, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • William Beaumont Hospital-Royal Oak Royal Oak, Michigan, United States
  • William Beaumont Hospital-Troy Troy, Michigan, United States
View Trial Details
Completed

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

NCT00168818

Conditions
Arthroplasty, Replacement, Hip, Cardiovascular Diseases, Embolism and Thrombosis, +2 more
Locations
  • 1160.48.06108 Canberra Hospital Garren, Australian Capital Territory, Australia
  • 1160.48.06106 St George Public Hospital Kogarah, New South Wales, Australia
  • 1160.48.06110 Suite 13 level 4 Lismore, New South Wales, Australia
  • 1160.48.06105 Flinders Medical Centre Bedford Park, South Australia, Australia
View all 116 locations
View Trial Details
Completed

RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery

NCT00168805

Conditions
Arthroplasty, Replacement, Knee, Cardiovascular Diseases, Embolism and Thrombosis, +2 more
Locations
  • 1160.25.06108 Boehringer Ingelheim Investigational Site Garren, Australian Capital Territory, Australia
  • 1160.25.06106 Boehringer Ingelheim Investigational Site Kogarah, New South Wales, Australia
  • 1160.25.06110 Boehringer Ingelheim Investigational Site Lismore, New South Wales, Australia
  • 1160.25.06105 Boehringer Ingelheim Investigational Site Bedford Park, South Australia, Australia
View all 105 locations
View Trial Details
Completed

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

NCT00680186

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations
  • 1160.46.01073 Boehringer Ingelheim Investigational Site Little Rock, Arkansas, United States
  • 1160.46.01044 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
  • 1160.46.01068 Boehringer Ingelheim Investigational Site Normal, Illinois, United States
  • 1160.46.01071 Boehringer Ingelheim Investigational Site Shreveport, Louisiana, United States
View all 220 locations
View Trial Details
Completed

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

NCT01225822

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations
  • 1160.19.43004 Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria
  • 1160.19.43002 Orthopädisches Spital Speising Vienna, Austria
  • 1160.19.43001 A.ö. Krankenhaus d. Statutarstadt Wiener Neustadt Wiener Neustadt, Austria
  • 1160.19.32002 V.U.B. Jette Brussels, Belgium
View all 59 locations
View Trial Details
Completed

Secondary Prevention of Venous Thrombo Embolism (VTE).

NCT00329238

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations
  • 1160.47.01035 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1160.47.01056 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • 1160.47.01044 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
  • 1160.47.01019 Boehringer Ingelheim Investigational Site Augusta, Georgia, United States
View all 275 locations
View Trial Details
Completed

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

NCT00423319

Conditions
Cardiovascular Diseases, Deep Vein Thrombosis, Embolism, +7 more
Locations
  • Capstone Clinical Trials, Inc Birmingham, Alabama, United States
  • West Alabama Research, Llc Birmingham, Alabama, United States
  • Martin Bowen Hefley Orthopedics Little Rock, Arkansas, United States
  • Orthoarkansas, P.A. Little Rock, Arkansas, United States
View all 143 locations
View Trial Details
Completed

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

NCT00152971

Conditions
Arthroplasty, Replacement, Knee, Cardiovascular Diseases, Embolism and Thrombosis, +2 more
Locations
  • 1160.24.01074 Capstone Clinical Trials, Inc. Birmingham, Alabama, United States
  • 1160.24.01079 West AL Research, Inc Northport, Alabama, United States
  • 1160.24.01047 Tucson Orhtopaedic Institute Tucson, Arizona, United States
  • 1160.24.01025 Martin, Bowen, Hefley Knee and Sports Little Rock, Arkansas, United States
View all 94 locations
View Trial Details

Related conditions